Preoperative elevated AFP also proved to be an independent risk factor for survival among recurrent HCC patients, with a 1.6-fold increased risk of death when compared to those with preoperative AFP < 20 ng/mL [65]. This evidence concerns the gene AFP and hepatocellular carcinoma.